<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In three groups of subjects, those with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, those with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> without <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, and healthy volunteers subjected to short-term <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, we observed a counterintuitive relationship </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> three groups, baseline renal plasma flow (RPF) was positively correlated with the RPF response to blocking the renin-angiotensin system (<z:mp ids='MP_0011356'>RAS</z:mp>) </plain></SENT>
<SENT sid="2" pm="."><plain>This seems paradoxical in that an opposite result would have been expected if angiotensin-dependent renal vasoconstriction was responsible for the renal <z:chebi fb="1" ids="35620">vasodilator</z:chebi> response to <z:mp ids='MP_0011356'>RAS</z:mp> blockade </plain></SENT>
<SENT sid="3" pm="."><plain>This suggests a link between the renal <z:chebi fb="1" ids="35620">vasodilator</z:chebi> response, mediated by nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO), and the activation of the intrarenal <z:mp ids='MP_0011356'>RAS</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The complex interrelationships between <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, insulin, NO, and the <z:mp ids='MP_0011356'>RAS</z:mp> may result in phenotypes that indicate varying risk of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and underlying genetic polymorphisms </plain></SENT>
</text></document>